Venkata Lakshmana R. Chunduru
Director/Board Member at LAURUS LABS LIMITED
Net worth: 73 M $ as of 30/04/2024
Profile
Venkata Lakshmana R.
Chunduru is currently an Executive Director at Laurus Labs Ltd.
and a Director at Sriam Labs Pvt Ltd.
He graduated and earned a doctorate degree from Andhra University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LAURUS LABS LTD.
2.50% | 30/09/2023 | 13,450,145 ( 2.50% ) | 73 M $ | 30/04/2024 |
Venkata Lakshmana R. Chunduru active positions
| Companies | Position | Start |
|---|---|---|
| LAURUS LABS LIMITED | Director/Board Member | 08/03/2018 |
Sriam Labs Pvt Ltd.
 Sriam Labs Pvt Ltd. Pharmaceuticals: MajorHealth Technology Sriam Labs Pvt Ltd. manufactures and supplies pharmaceutical products. Its product portfolio includes biperidine hydrochloride, biperidine base, flavoxate hydrochloride, famciclovir, labetalol hydrochloride, memantine hydrochloride, moxifloxacin hydrochloride and trimipramine. The company was founded in 2002 and is headquartered in Hyderabad, India. | Director/Board Member | 25/07/2014 |
Training of Venkata Lakshmana R. Chunduru
| Andhra University | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LAURUS LABS LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
Sriam Labs Pvt Ltd.
Sriam Labs Pvt Ltd. Pharmaceuticals: MajorHealth Technology Sriam Labs Pvt Ltd. manufactures and supplies pharmaceutical products. Its product portfolio includes biperidine hydrochloride, biperidine base, flavoxate hydrochloride, famciclovir, labetalol hydrochloride, memantine hydrochloride, moxifloxacin hydrochloride and trimipramine. The company was founded in 2002 and is headquartered in Hyderabad, India. | Health Technology |
- Stock Market
- Insiders
- Venkata Lakshmana R. Chunduru
